IL36G and ovarian carcinoma: On the other hand, the concentration of IL-36β and IL-36γ in the case of the reference group, the group of patients in stage G1, G2 and G3, remained at low levels, not statistically significant between the mentioned groups, which in this case may suggest the lack of involvement of the studied interleukins in the process of carcinogenesis of ovarian cancer, and thus on the anti-tumor role of these interleukins.